Trial

The 25-person study will look at the effects of pharmacist-led home blood pressure monitoring and medication reminders on people with hypertension.

Called C Tracker, the study will give researchers insight into patients' daily activity, monitor symptoms and assess the efficacy of treatments.

Also the three studies Adherium has conducted have found a 14.9% increase in lung function and a 37% reduction in oral steroid usage.

The 2-year study of 710 patients with coronary heart disease showed that six months of a text messaging intervention can produce significant results.

Higi reviewed its user base and analyzed the impacts of its system on 159,000 hypertensive users across the U.S. from September 2012 to April 2015.

The study participants were asked to complete daily questionnaires over a 36-week period regarding the use of an Army-developed messaging app called mCare.

The approval will allow the company to launch its long-term continuous remote monitoring device on the European market in the near future.

The two parties are integrating their respective technology platforms to drive patient-centric research by including data from sensors, wearables and apps.

The solution was developed with cooperation from Qualcomm Life, Novartis and PPD, which are also supporting a pilot clinical study before broad commercial use.

At the end of the six-week trial, 71% of participants reported increased awareness of activity, sleep or eating habits; and 45% reported increased motivation.